Surgical Science Sweden AB (publ) (SUS.ST)

SEK 154.5

(0.85%)

Total Liabilities Summary of Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ)'s latest annual total liabilities in 2023 was 357.46 Million SEK , down -13.47% from previous year.
Surgical Science Sweden AB (publ)'s latest quarterly total liabilities in 2024 Q2 was 369.72 Million SEK , down -0.29% from previous quarter.
Surgical Science Sweden AB (publ) reported annual total liabilities of 413.11 Million SEK in 2022, up 5.1% from previous year.
Surgical Science Sweden AB (publ) reported annual total liabilities of 393.05 Million SEK in 2021, up 769.14% from previous year.
Surgical Science Sweden AB (publ) reported quarterly total liabilities of 370.79 Million SEK for 2024 Q1, up 3.73% from previous quarter.
Surgical Science Sweden AB (publ) reported quarterly total liabilities of 357.46 Million SEK for 2023 Q4, down -10.8% from previous quarter.

Annual Total Liabilities Chart of Surgical Science Sweden AB (publ) (2023 - 2014)

Historical Annual Total Liabilities of Surgical Science Sweden AB (publ) (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	357.46 Million SEK	-13.47%
2022	413.11 Million SEK	5.1%
2021	393.05 Million SEK	769.14%
2020	45.22 Million SEK	-17.08%
2019	54.53 Million SEK	168.97%
2018	20.27 Million SEK	51.32%
2017	13.39 Million SEK	-67.56%
2016	41.3 Million SEK	17.66%
2015	35.1 Million SEK	200.86%
2014	11.66 Million SEK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	369.72 Million SEK	-0.29%
2024 Q1	370.79 Million SEK	3.73%
2023 Q4	357.46 Million SEK	-10.8%
2023 FY	357.46 Million SEK	-13.47%
2023 Q1	416.44 Million SEK	0.81%
2023 Q2	448.03 Million SEK	7.59%
2023 Q3	400.74 Million SEK	-10.56%
2022 Q2	429.91 Million SEK	3.84%
2022 Q4	413.11 Million SEK	-11.66%
2022 Q3	467.64 Million SEK	8.78%
2022 Q1	414.03 Million SEK	5.34%
2022 FY	413.11 Million SEK	5.1%
2021 Q2	204.08 Million SEK	-2.54%
2021 Q3	399.54 Million SEK	95.78%
2021 FY	393.05 Million SEK	769.14%
2021 Q4	393.05 Million SEK	-1.62%
2021 Q1	209.39 Million SEK	363.01%
2020 Q2	51.12 Million SEK	-0.46%
2020 FY	45.22 Million SEK	-17.08%
2020 Q3	42.16 Million SEK	-17.53%
2020 Q4	45.22 Million SEK	7.26%
2020 Q1	51.36 Million SEK	-5.82%
2019 Q2	26.92 Million SEK	0.0%
2019 FY	54.53 Million SEK	168.97%
2019 Q4	54.53 Million SEK	-11.78%
2019 Q3	61.82 Million SEK	129.6%
2019 Q1	26.92 Million SEK	32.8%
2018 Q4	20.27 Million SEK	53.61%
2018 FY	20.27 Million SEK	51.32%
2018 Q1	13.3 Million SEK	-0.74%
2018 Q2	13.7 Million SEK	3.01%
2018 Q3	13.2 Million SEK	-3.65%
2017 Q1	38.3 Million SEK	-7.26%
2017 Q2	9.7 Million SEK	-74.67%
2017 FY	13.39 Million SEK	-67.56%
2017 Q3	12.1 Million SEK	24.74%
2017 Q4	13.39 Million SEK	10.74%
2016 FY	41.3 Million SEK	17.66%
2016 Q1	- SEK	0.0%
2016 Q4	41.3 Million SEK	0.0%
2015 FY	35.1 Million SEK	200.86%
2014 FY	11.66 Million SEK	0.0%

Peer Total Liabilities Comparison of Surgical Science Sweden AB (publ)

Name	Total Liabilities	Total Liabilities Difference
Aino Health AB (publ)	14.36 Million SEK	-2388.416%
Bonzun AB (publ)	6.95 Million SEK	-5043.324%
Kontigo Care AB (publ)	19.05 Million SEK	-1776.239%
Medhelp Care Aktiebolag (publ)	36.98 Million SEK	-866.477%
RaySearch Laboratories AB (publ)	1.21 Billion SEK	70.638%